Wednesday, July 20, 2016

BRIEF-Apex therapeutics announces FDA acceptance of IND to evaluate tolerability, anti-tumor effects of APX3330

* Announces FDA acceptance of IND to evaluate the

tolerability and anti-tumor effects of APX3330

Source text for Eikon:

(Bengaluru Newsroom : +1-646-223-8780)

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)